Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
The report details the trend, potential and market size of Cancer Biomarker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Biomarkermarket, defines the market attractiveness level of Cancer Biomarker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Biomarker industry, describes the types of Cancer Biomarker market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Biomarker market and the development prospects and opportunities of Cancer Biomarker industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Biomarker market in Chapter 13.
By Player:
Merck & Co
Danaher Corporation
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Biomérieux SA
GE Healthcare
Hologic
Thermo Fisher Scientific
Myriad Genetics
Roche Diagnostics
Qiagen
Sysmex Corporation
Quest Diagnostics
Illumina
Bio-Rad Laboratories
By Type:
Protein Biomarker
Genetic Biomarker
By End-User:
Diagnostics
Research
Prognostics
Risk Assessment
Other Applications
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Biomarker Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Biomarker Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Biomarker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Biomarker Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Biomarker Market Analysis and Outlook to 2022
-
7.1 Global Cancer Biomarker Consumption (2017-2022)
-
7.2 United States Cancer Biomarker Consumption (2017-2022)
-
7.3 Europe Cancer Biomarker Consumption (2017-2022)
-
7.4 China Cancer Biomarker Consumption (2017-2022)
-
7.5 Japan Cancer Biomarker Consumption (2017-2022)
-
7.6 India Cancer Biomarker Consumption (2017-2022)
-
7.7 South Korea Cancer Biomarker Consumption (2017-2022)
8 Region and Country-wise Cancer Biomarker Market Analysis and Outlook to 2028
-
8.1 Global Cancer Biomarker Consumption Forecast (2022-2028)
-
8.2 United States Cancer Biomarker Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Biomarker Consumption Forecast (2022-2028)
-
8.4 China Cancer Biomarker Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Biomarker Consumption Forecast (2022-2028)
-
8.6 India Cancer Biomarker Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Biomarker Consumption Forecast (2022-2028)
9 Global Cancer Biomarker Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Biomarker Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Protein Biomarker Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Genetic Biomarker Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Biomarker Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diagnostics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Prognostics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Risk Assessment Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Applications Consumption and Growth Rate (2017-2022)
10 Global Cancer Biomarker Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Biomarker Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Protein Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Genetic Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Biomarker Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Prognostics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Risk Assessment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Biomarker Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Biomarker Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Biomarker Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Biomarker Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Biomarker Market Competitive Analysis
-
14.1 Merck & Co
-
14.1.1 Merck & Co Company Details
-
14.1.2 Merck & Co Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Cancer Biomarker Product and Service
-
14.2 Danaher Corporation
-
14.2.1 Danaher Corporation Company Details
-
14.2.2 Danaher Corporation Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Danaher Corporation Cancer Biomarker Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Cancer Biomarker Product and Service
-
14.4 Agilent Technologies
-
14.4.1 Agilent Technologies Company Details
-
14.4.2 Agilent Technologies Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Agilent Technologies Cancer Biomarker Product and Service
-
14.5 Becton, Dickinson and Company
-
14.5.1 Becton, Dickinson and Company Company Details
-
14.5.2 Becton, Dickinson and Company Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Becton, Dickinson and Company Cancer Biomarker Product and Service
-
14.6 Biomérieux SA
-
14.6.1 Biomérieux SA Company Details
-
14.6.2 Biomérieux SA Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biomérieux SA Cancer Biomarker Product and Service
-
14.7 GE Healthcare
-
14.7.1 GE Healthcare Company Details
-
14.7.2 GE Healthcare Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GE Healthcare Cancer Biomarker Product and Service
-
14.8 Hologic
-
14.8.1 Hologic Company Details
-
14.8.2 Hologic Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Hologic Cancer Biomarker Product and Service
-
14.9 Thermo Fisher Scientific
-
14.9.1 Thermo Fisher Scientific Company Details
-
14.9.2 Thermo Fisher Scientific Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Thermo Fisher Scientific Cancer Biomarker Product and Service
-
14.10 Myriad Genetics
-
14.10.1 Myriad Genetics Company Details
-
14.10.2 Myriad Genetics Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Myriad Genetics Cancer Biomarker Product and Service
-
14.11 Roche Diagnostics
-
14.11.1 Roche Diagnostics Company Details
-
14.11.2 Roche Diagnostics Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Roche Diagnostics Cancer Biomarker Product and Service
-
14.12 Qiagen
-
14.12.1 Qiagen Company Details
-
14.12.2 Qiagen Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Qiagen Cancer Biomarker Product and Service
-
14.13 Sysmex Corporation
-
14.13.1 Sysmex Corporation Company Details
-
14.13.2 Sysmex Corporation Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sysmex Corporation Cancer Biomarker Product and Service
-
14.14 Quest Diagnostics
-
14.14.1 Quest Diagnostics Company Details
-
14.14.2 Quest Diagnostics Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Quest Diagnostics Cancer Biomarker Product and Service
-
14.15 Illumina
-
14.15.1 Illumina Company Details
-
14.15.2 Illumina Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Illumina Cancer Biomarker Product and Service
-
14.16 Bio-Rad Laboratories
-
14.16.1 Bio-Rad Laboratories Company Details
-
14.16.2 Bio-Rad Laboratories Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Bio-Rad Laboratories Cancer Biomarker Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Biomarker
-
Figure Cancer Biomarker Picture
-
Table Global Cancer Biomarker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Biomarker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Biomarker Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Biomarker Consumption by Country (2017-2022)
-
Figure United States Cancer Biomarker Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Biomarker Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Biomarker Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Biomarker Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Biomarker Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protein Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Biomarker Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Consumption and Growth Rate (2017-2022)
-
Figure Global Prognostics Consumption and Growth Rate (2017-2022)
-
Figure Global Risk Assessment Consumption and Growth Rate (2017-2022)
-
Figure Global Other Applications Consumption and Growth Rate (2017-2022)
-
Figure Global Protein Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Biomarker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prognostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Risk Assessment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Biomarker Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Biomarker Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Cancer Biomarker Product and Service
-
Table Danaher Corporation (Foundation Year, Company Profile and etc.)
-
Table Danaher Corporation Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation Cancer Biomarker Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Cancer Biomarker Product and Service
-
Table Agilent Technologies (Foundation Year, Company Profile and etc.)
-
Table Agilent Technologies Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Cancer Biomarker Product and Service
-
Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)
-
Table Becton, Dickinson and Company Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton, Dickinson and Company Cancer Biomarker Product and Service
-
Table Biomérieux SA (Foundation Year, Company Profile and etc.)
-
Table Biomérieux SA Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomérieux SA Cancer Biomarker Product and Service
-
Table GE Healthcare (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Cancer Biomarker Product and Service
-
Table Hologic (Foundation Year, Company Profile and etc.)
-
Table Hologic Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hologic Cancer Biomarker Product and Service
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Cancer Biomarker Product and Service
-
Table Myriad Genetics (Foundation Year, Company Profile and etc.)
-
Table Myriad Genetics Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myriad Genetics Cancer Biomarker Product and Service
-
Table Roche Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Roche Diagnostics Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Diagnostics Cancer Biomarker Product and Service
-
Table Qiagen (Foundation Year, Company Profile and etc.)
-
Table Qiagen Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Cancer Biomarker Product and Service
-
Table Sysmex Corporation (Foundation Year, Company Profile and etc.)
-
Table Sysmex Corporation Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sysmex Corporation Cancer Biomarker Product and Service
-
Table Quest Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Quest Diagnostics Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Cancer Biomarker Product and Service
-
Table Illumina (Foundation Year, Company Profile and etc.)
-
Table Illumina Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina Cancer Biomarker Product and Service
-
Table Bio-Rad Laboratories (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories Cancer Biomarker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Cancer Biomarker Product and Service
-
